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Accepted 19 October; published on WWW 3 December 1998Placodes are discrete regions of thickened ectoderm that
contribute extensively to the peripheral nervous system in
the vertebrate head. The paired-domain transcription
factor Pax-3 is an early molecular marker for the avian
ophthalmic trigeminal (opV) placode, which forms sensory
neurons in the ophthalmic lobe of the trigeminal ganglion.
Here, we use collagen gel cultures and heterotopic quail-
chick grafts to examine the competence, specification and
induction of Pax-3 in the opV placode. At the 3-somite
stage, the whole head ectoderm rostral to the first somite is
competent to express Pax-3 when grafted to the opV
placode region, though competence is rapidly lost
thereafter in otic-level ectoderm. Pax-3 specification in
presumptive opV placode ectoderm occurs by the 8-somite
stage, concomitant with robust Pax-3 expression. From the
8-somite stage onwards, significant numbers of cells are
committed to express Pax-3. The entire length of the neural
tube has the ability to induce Pax-3 expression in
competent head ectoderm and the inductive interaction is
direct. We propose a detailed model for Pax-3 induction in
the opV placode.
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SUMMARYINTRODUCTION
In vertebrate embryos, the formation of the sense organs (nose,
eyes, ears and lateral line) and the cranial sensory ganglia is
substantially dependent on the contribution of cells from
cranial ectodermal placodes (reviewed by Webb and Noden,
1993; Le Douarin et al., 1986). Placodes, discovered over a
century ago by van Wijhe (1883), are focal regions of
thickened columnar epithelium that form in characteristic
positions in the cranial ectoderm. The adenohypophyseal
placode forms the anterior pituitary gland, while the lens
placode forms the crystallin-secreting lens cells of the eye. The
olfactory, otic and lateral line placodes give rise to the nose,
ear and lateral line system, respectively. These three placodes
form a wide variety of cell types, including ciliated sensory
receptors, sensory neurons, neuroendocrine cells, glia and
other supporting cells (see Webb and Noden, 1993; Muske,
1993 for reviews). The trigeminal and epibranchial (geniculate,
petrosal and nodose) placodes give rise only to sensory neurons
in cranial sensory ganglia (D’Amico-Martel and Noden, 1983).
The mechanisms underlying the formation of different
placodes remain unclear, because there have been few early
markers for placodes until very recently. Information on
placode induction is essentially only available for the lens,
olfactory and otic placodes, which form morphologically
identifiable derivatives. Classical embryological grafting
experiments in amphibian embryos have shown that theinduction of the lens, nose and ear is a lengthy, cumulative
process that begins during gastrulation (reviewed by Jacobson
and Sater, 1988; Grainger, 1992, 1996). Induction of all three
organs involves a series of different inducers from different
tissues, including underlying mesoderm or endoderm and
adjacent neural tissue (ibid.). Owing to this complexity, and in
the absence of early molecular markers, it is very difficult to
identify candidate inducing molecules through their expression
patterns or to design assays to identify inducing molecules
directly (as stressed by Gurdon, 1987). Today, however, such
early markers have been identified for many placodes. Pax-6 is
expressed in the lens and olfactory placodes (Walther and
Gruss, 1991), Nkx5-1 and Pax-2 in the otic placode (Herbrand
et al., 1998), c-Kit-related kinase 1, Msx-2 and Dlx-3 in lateral
line placodes (Baker et al., 1995; Metscher et al., 1997), Pax-
3, FREK and neurogenin-1 in the trigeminal placode (Stark et
al., 1997; Sommer et al., 1996) and neurogenin-2 in the
epibranchial placodes (Sommer et al., 1996). Very recently,
Otx-2, Sox-3 and Pax-6 have been identified as markers for
presumptive lens ectoderm in some of the earliest stages of lens
placode induction (Zygar et al., 1998; also see Altmann et al.,
1997). The use of these early markers, in combination with
classically defined information on the location and timing of
induction, raises the exciting prospect of being able to identify
the molecules involved in placode induction.
The availability of molecular markers also means that it is
possible to study the induction of placodes lacking
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epibranchial placodes. In a previous study (Stark et al., 1997),
we identified the paired-domain homeobox transcription factor
Pax-3 as an early marker of the avian ophthalmic trigeminal
(opV) placode. This placode gives rise to sensory neurons in
the ophthalmic lobe of the trigeminal ganglion (opV). We
showed using ablation and barrier implantation experiments
that a diffusible signal from the midbrain/rostral hindbrain is
necessary for Pax-3 induction or maintenance in the opV
placode (Stark et al., 1997). In order to understand the cellular
and molecular mechanisms underlying the induction of the
opV placode, it is necessary to analyse the spatial and temporal
organisation of Pax-3 induction in presumptive opV placode
ectoderm. Here, we have used collagen gel cultures and
classical embryological grafting techniques to determine: (1)
which regions of the early embryo are competent to express
Pax-3 protein in response to the Pax-3-inducing activity, (2)
when presumptive opV placode ectoderm is specified and
committed to express Pax-3 protein; and (3) where and when
the Pax-3-inducing activity is present. We present a detailed
model for Pax-3 induction in the opV placode.
MATERIALS AND METHODS
Quail-chick grafts
Fertilized quail (Coturnix coturnix japonica) and chick (Gallus gallus
domesticus, White Leghorn) eggs were obtained from commercial
sources and incubated at 38°C in a humidified atmosphere. Embryos
were staged according to the number of somites formed. A window
was cut in the quail shell and a 1:10 mixture of India ink and Ringer’s
solution injected into the sub-blastodermal cavity to reveal the
embryo. The vitelline membrane in the region of the surgery, and the
ectodermal region to be grafted, were removed using a pulled glass
needle. The chick embryo host was similarly prepared and the
ectoderm from the region of the graft site was removed immediately
before transfer of the donor ectoderm.
Collagen gel cultures
Ectoderm explants for collagen gel cultures were removed as
described above, or after enzymatic treatment to enable clean isolation
of the ectoderm from underlying mesenchyme or neural crest cells.
Other embryonic tissues (neural tube, mesoderm) were also dissected
out following enzymatic treatment. Briefly, explanted quail and chick
embryos were incubated in 1.5 mg/ml Dispase (Boehringer
Mannheim) in DMEM with 20 mM Hepes, pH 8.0 for 20 minutes on
ice and 15 minutes at 37°C. After recovery on ice in complete medium
(10% horse serum, 15% chick embryonic extract in DMEM) for at
least 10 minutes, the embryos were removed into Ringer’s solution
and the desired tissue dissected out using pulled glass needles or
30G1/2 syringe needles. Explants were stored on ice in complete
medium until ready to be placed in collagen gel culture, when they
were rinsed for 5-10 minutes on ice in Ringer’s solution. Collagen
matrix gels were prepared as previously described (Artinger and
Bronner-Fraser, 1993) except that commercially produced collagen
was used (Collaborative Research). The bottom layer (10 m l collagen)
was allowed to set for 20 minutes at room temperature before the
explants were added. The top layer (4 m l collagen) was allowed to set
for 15 minutes at room temperature before addition of F-12 medium
plus N-2 supplements (Gibco-BRL). Cultures were incubated at 38°C,
5% CO2 for 9-24 hours.
Immunohistochemistry
Embryos and collagen gels were collected after 0 to 27 hours of
incubation, fixed in 4% paraformaldehyde for 2 hours at roomtemperature and processed for cryostat sectioning as described by
Sechrist et al. (1995). 12-16 m m sections were mounted on
Superfrost® Plus glass slides (Fisher) and the gelatin removed by
treating the slides in phosphate-buffered saline (PBS) at 42°C for 5
minutes. Slides were incubated 2-4 hours in primary antibody
solution, and 1-2 hours in secondary antibody solution, with three 5-
minute washes after each incubation. For collagen gel specimens,
DAPI was present at 10 m g/ml in the final wash. Slides were mounted
in Fluoromount-G (Southern Biotechnology Associates, Inc.) and
viewed by fluorescent microscopy. Only those chimeras that had
successfully incorporated the donor graft were scored for Pax-3-
expressing quail cells. All sections were scored blind.
Antibodies were diluted in antibody buffer consisting of 0.1% BSA
and 0.1% Triton in PBS. Primary antibody solution consisted of 1:1
QCPN supernatant (Developmental Hybridoma Bank, University of
Iowa) and 1:5000 Pax-3 ascites (C. M., T. Wong, M. R. S., C. Ordahl
and M. B.-F., unpublished data) in antibody buffer. Secondary
antibody solution for quail-chick chimeras and collagen gel co-
cultures consisted of 1:400 goat anti-mouse IgG1-TRITC and 1:200
goat anti-mouse IgG2a-FITC (Southern Biotechnology Associates,
Inc.) in antibody buffer. Secondary antibody solution for collagen gel
specimens (quail tissue only) consisted of 1:300 goat anti-mouse IgG-
Hi-FITC (Antibodies Inc.) in antibody buffer. For neurofilament
staining, primary antibody solution consisted of 1:300 monoclonal
antibody RMO 270.3 (Lee et al., 1987; gift of Dr Virginia Lee);
secondary antibody solution consisted of 1:300 goat anti-mouse IgG-
Hi-FITC (Antibodies, Inc.).
RESULTS
Time course of Pax-3 protein expression in opV
placode ectoderm
Pax-3 mRNA can be detected in the dorsal neural tube and in
the cranial neural folds and immediately adjacent surface
ectoderm as early as the 3-somite stage (3-ss) in quail and chick
embryos. As development proceeds, high levels of Pax-3
mRNA can be detected only in opV placode cells (Stark et al.,
1997). Here, we used an anti-Pax-3 antibody to study the time
course of Pax-3 protein expression. Pax-3 protein, in contrast
to Pax-3 mRNA, cannot be detected above background in the
dorsal neural tube, the neural crest or in the surface ectoderm
prior to the 6-ss in quail or chick embryos. In 7-ss quail
embryos, low levels of Pax-3 protein can be detected in
ectoderm immediately adjacent to the midbrain, and also in
neural crest cells migrating immediately beneath this ectoderm,
with a few cells expressing slightly higher levels (Fig. 1A). In
8- to 9-ss quail embryos, neural crest cells in the presumptive
opV placode region express roughly the same level of Pax-3
protein, while a few additional surface ectoderm cells begin to
express higher levels (data not shown). In 10-ss embryos,
several surface ectoderm cells express high levels of Pax-3
protein, while the underlying neural crest cells express
comparatively lower levels (Fig. 1B). In 12- to 15-ss embryos,
high levels of Pax-3 protein are seen in opV placodal ectoderm.
After the 15-ss, Pax-3 protein expression in neural crest cells
becomes virtually undetectable (Fig. 1C,D). By the 19-ss, both
surface ectoderm and several placode-derived cells in the
mesenchyme (see Stark et al., 1997) express high levels of Pax-
3 protein (Fig. 1E). The first detectable Pax-3 protein
expression in young chick embryos lags 1- to 2-ss behind
expression in quail embryos, but otherwise chick and quail
show identical Pax-3 expression patterns.
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about the level of rhombomeres 2 and 3 (r2,3) also expresses
Pax-3 mRNA (Stark et al., 1997) as well as low levels of Pax-
3 protein. This includes mesoderm around the otic vesicles at
young stages (up to about the 10-ss) and presomitic and somitic
mesoderm at all stages examined (data not shown; see Stark et
al., 1997 for mRNA expression). Also, migrating neural crest
cells rostral and caudal to the otic vesicle express Pax-3 mRNA
and protein at an intermediate level during their migration.
Therefore, grafts involving otic-level ectoderm and more
caudal regions were only scored for Pax-3 expression in quail
surface ectoderm i.e. in columnar epithelium at the surface of
the embryo. At all stages examined, the antibody is specific for
cells expressing Pax-3 mRNA; it does not crossreact with cells
expressing other Pax family gene members, such as Pax-2-
expressing otic placode cells (C. M., T. Wong, M. R. S., C.
Ordahl and M. B.-F., unpublished data).
Only head ectoderm rostral to the first-formed
somite is competent to express Pax-3
In order to determine the spatial extent of competence to
express Pax-3, surface ectoderm from various regions of 2- to
11-ss quail donors was grafted into the presumptive opV
placode next to the midbrain and rhombomere 1 (region A) of
3- to 8-ss chick hosts (Fig. 2A). This definition of the
presumptive opV placode is based on the placodal fate-map of
D’Amico-Martel and Noden (1983), our own previous quail-
chick grafting experiments (Baker et al., 1997) and the early
Pax-3 mRNA expression pattern in the cranial ectoderm (Stark
et al., 1997). None of the ectodermal regions grafted into the
presumptive opV placode, except presumptive opV placode
itself at later stages, normally express Pax-3 mRNA (Stark et
al., 1997). Chimeras were scored for Pax-3-positive quail cells
after 15-24 hours of incubation. The results are presented
graphically in Fig. 2B.
Pre-otic ectoderm
Forebrain-level ectoderm from 2- to 4-ss donors gave rise to
many (>20) Pax-3-positive cells in all cases (F-A grafts).
Although olfactory placode ectoderm, which fate-maps to the
neural folds at the 3-ss (Couly and Le Douarin, 1985), goes on
to express Pax-3 mRNA, 2- to 4-ss forebrain-level ectoderm
does not express Pax-3 mRNA (Stark et al., 1997).
Isotopic grafts of midbrain-level ectoderm from 4- to 7-ss
donors gave rise to many (>20) Pax-3-positive cells in all cases
(A-A grafts; Fig. 2C-E). Ectoderm lateral to rhombomeres 2
and 3 (r2,3) from 6- to 9-ss donors gave rise to some (5-20)
Pax-3-positive cells in 86% of cases (B-A grafts; donors
younger than 6-ss could not be used as the rhombomere
boundaries could not be distinguished). Although r2,3-level
ectoderm does not express Pax-3 mRNA in unoperated
embryos (Stark et al., 1997), and this ectoderm does not
contribute cells to the opV ganglion (D’Amico-Martel and
Noden, 1983), we confirmed that it does not normally give rise
to Pax-3-positive cells by performing isotopic grafts at this
level: Pax-3-positive quail cells were never seen in the resultant
chimeras (n=5).
Otic-level ectoderm
Otic-level ectoderm was defined in 2- to 3-ss embryos as the
ectoderm rostral to the first-formed somite, based on the fate-map of Couly and Le Douarin (1990) and on our own isotopic
grafts (data not shown). Ectoderm from the otic region of 2- to
3-ss donors gave rise to a few (<10) Pax-3-positive quail
ectoderm cells in 88% of cases (C-A grafts). In contrast, otic-
level ectoderm from older embryos (4- to 9-ss donors) never
formed Pax-3-positive cells. This suggests that the competence
of otic-level ectoderm to express Pax-3 is rapidly lost after the
3-ss. Ectopic quail-derived otic vesicle-like structures were
often found after otic-level ectoderm grafts from older
embryos. In isotopic grafts of otic-level ectoderm from 3- to
4-ss donors, no Pax-3-positive quail cells were seen (n=3),
again confirming that this region does not normally give rise
to Pax-3-expressing cells.
Postotic ectoderm
Presumptive nodose placode ectoderm was defined as the
ectoderm overlying and lateral to the first two-formed somites
(D’Amico-Martel and Noden, 1983). Ectoderm from the
presumptive nodose placode region of 3- to 6-ss donors never
gave rise to Pax-3-positive ectoderm cells (D-A grafts).
Ectoderm from the trunk of 3- to 11-ss donors, whether from
over the somites or lateral plate mesoderm, lateral to the open
neural plate, or lateral to Hensen’s node, likewise never gave
rise to Pax-3-positive ectoderm cells (L/M-A grafts).
In summary, only head ectoderm rostral to the first-formed
somite is competent to express Pax-3 when grafted adjacent to
the midbrain. Competence is highest in more rostral ectoderm
(forebrain- and midbrain-level ectoderm). Competence at the
otic level is lost after the 3-ss, while competence at the r2,3
level is retained until at least the 9-ss (the latest stage tested).
Competence to express Pax-3 is present at gastrula
stages
In order to determine how early in development we can detect
competence to express Pax-3, we took prospective ectoderm
(García-Martinez et al., 1993) from the lateral margins of
Hamburger-Hamilton (HH) stage 3+ quail epiblasts
(Hamburger and Hamilton, 1951) and grafted it into the
presumptive opV placode region of 6- to 8-ss chick hosts. In
all cases, the grafted tissue formed at least some (3-30) Pax-3-
positive cells (n=5); however, these were always localised to
particular regions of the graft, usually its caudal margin. Grafts
taken from the lateral margins of HH stage 5 embryos formed
many (>20) Pax-3-positive cells in 75% of 3- to 5-ss hosts
(n=4). Hence, competence to express Pax-3 is present, at least
to some extent, in the epiblast as early as HH stage 3+.
Pax-3 specification does not occur significantly
before Pax-3 expression
A tissue is specified to follow a particular developmental
pathway if it follows that pathway when isolated from the
embryo and cultured in a neutral medium, i.e. in the absence
of other embryonic signals (Slack, 1991). In order to test when
presumptive opV placode ectoderm becomes specified to
express Pax-3, we explanted midbrain-level ectoderm pieces
from 3- to 13-ss quail donors and cultured them in collagen
gels without serum for 9-22 hours. The explanted region was
taken a little lateral to the midbrain to avoid accidental
extirpation of neural tissue, and is devoid of Pax-3 mRNA
expression at the 3-ss (Stark et al., 1997). Couly and Le
Douarin (1990) found the anlage of the opV placode to be
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Fig. 1. Transverse sections through the midbrain region of quail (A-C)
and chick (D,E) embryos stained with the anti-Pax-3 antibody to show
the normal time course of Pax-3 protein expression in the opV
placode. (A) 7-ss quail embryo, showing low levels of Pax-3 protein
in the migrating neural crest (NC) and overlying presumptive placodal
ectoderm (PL). (B) 10-ss quail embryo, showing low Pax-3
expression in migrating neural crest cells and higher expression in
presumptive opV placode cells. (C) 12-ss quail embryo, showing high
Pax-3 expression in the presumptive opV placode and low expression
in some neural crest cells. (D) 15-ss chick embryo, showing high Pax-
3 expression in the opV placode. (E) 19-ss chick embryo, showing
high Pax-3 expression in the opV placode and in migrating placodal
cells (see Stark et al., 1997). NC, neural crest cells; PL, placode cells.contained entirely within the neural folds at the 3-somite stage
(3-ss). In our hands, however, competent ectoderm grafted next
to the midbrain at the 3-ss forms neurons in the opV ganglion
(data not shown). The results were pooled into four time-
periods: 3- to 4-ss, 5- to 7-ss, 8- to 9-ss and 10- to 13-ss. Since
one somite-stage is approximately 1.5 hours, these periods are
short relative to cell cycle time in the ectoderm, which is
around 10 hours at this stage (Smith and Schoenwolf, 1987).Fig. 2. Analysis of the distribution of ectoderm
competent to express Pax-3 in response to the
midbrain-level-inducing activity. (A) Different
ectoderm regions from quail donors were grafted at
the midbrain level of chick hosts. (B) Histogram of
the results. Each column represents the percentage of
chimeras with Pax-3-positive quail cells; the total
number of grafts performed (n) is marked at the top
of each column. Shown are forebrain-level grafts 
(F-A, 100%), isotopic midbrain-level grafts (A-A,
100%), r2-3-level ectoderm grafts (B-A, 86%), otic-
level ectoderm grafts (C-A, 2- to 3-ss donors, 88%:
C-A, 4-ss and older donors; 0%), and trunk-level
ectoderm grafts (L/M-A, 0%). Forebrain- and
midbrain-level grafts (F-A and A-A) yielded many
more Pax-3-positive cells per graft than did r2,3- or
2- to 3-ss otic-level grafts (B-A and C-A). 
(C-E) Transverse section through the midbrain region
of a chick host collected 20 hours after receiving an
isotopic graft of 5-ss midbrain-level quail ectoderm.
(C) FITC-labelled Pax-3-positive cells appear green.
(D) TRITC-labelled QCPN-positive quail cells
appear red. (E) Pax-3-positive quail cells appear
yellow when the green and red channels are merged.
Pax-3-positive chick cells can be seen in the
ectoderm dorsal to the Pax-3-positive quail ectoderm.After sectioning the collagen gels, we immunostained them
with the anti-Pax-3 antibody to identify Pax-3-expressing cells,
and labelled them with DAPI to follow cell death. We found
that after 12 hours of incubation, there was substantial cell
death in any adhering mesenchyme or neural crest, but the
ectoderm remained healthy. The results are presented
graphically in Fig. 3A. A few (<5) faintly Pax-3-positive cells
were seen in 14% of 3- to 4-ss explants, and a few (1-6) cells
were seen in 24% of 5- to 7-ss explants. At the 8- to 9-ss, 55%
of explants contained at least a few (1-10) Pax-3-positive cells,
most of which showed intermediate to bright staining (Fig.
3B). Half of the 8- to 9-ss embryos were treated with dispase
to allow ectoderm removal without adhering neural crest cells,
which migrate beneath the explanted midbrain-level ectoderm
from the 8-ss onwards (see Fig. 1). The presence or absence of
neural crest cells had no effect on the results (58% of untreated
explants yielded Pax-3-positive cells, compared with 52% of
explants from dispase-treated embryos). Given the in vivo
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Fig. 3. Time course of specification of presumptive opV placode
ectoderm to express Pax-3 protein. Midbrain-level ectoderm explants
were cultured in collagen gels without serum for 9-22 hours,
sectioned and scored for Pax-3-positive cells. (A) Histogram
showing the percentage of collagen gel-cultured explants with Pax-3-
positive cells at different donor stages. The number of explants (n) is
listed at the top of each column. Before the 8- to 9-ss, only a few
Pax-3-positive cells are seen per explant. From the 8- to 9-ss,
increasing numbers of cells with higher levels of expression are seen.
(B) Pax-3 protein expression in dispase-treated 8-ss midbrain-level
ectoderm cultured for 20 hours. Dispase treatment to remove
underlying neural crest cells had no effect on Pax-3 expression (see
text). (C) Pax-3 protein expression in isolated 12-ss midbrain-level
ectoderm cultured for 18 hours.
. Time course of commitment of presumptive opV placode ectoderm to
ss Pax-3 protein. Midbrain-level ectoderm was grafted from quail
rs into the trunk of chick hosts, over the intermediate and lateral plate
derm. Chimeras were sectioned and scored for Pax-3-positive quail
 (A) Histogram showing the percentage of chimeras with Pax-3-positive
 cells after grafts from different donor stages. The number of grafts (n)
ed at the top of each column. Before the 8-ss, only a few Pax-3-positive
are seen per embryo. From the 8-ss onwards, many Pax-3-positive cells
en.expression pattern (Fig. 1), the 8- to 9-ss is probably when Pax-
3 protein begins to be expressed at higher levels in the
explanted region. By the 10- to 13-ss, all explants contained at
least a few, and usually many (2-20 or more) Pax-3-
positive cells, most of which stained brightly (Fig.
3C). The intensity of staining and the number of Pax-
3-positive cells increased with the age of the explant:
brightly staining cells, and explants containing more
than ten Pax-3-positive cells, were only found after the
8-ss. Thus, specification of significant numbers of
cells in the explanted region occurs from the 8-ss
onwards, which is when observable Pax-3 protein
expression begins in this region in vivo.
Presumptive opV placode ectoderm is
committed to express Pax-3 from the 8-ss
A tissue is committed to follow a particular
developmental pathway if it still follows that pathway
when grafted elsewhere in the embryo, i.e. when it is
exposed to other embryonic signals. In order to test
when presumptive opV placode ectoderm becomes
committed to express Pax-3, we grafted midbrain-
level ectoderm from 4- to 11-ss quail embryos into the
trunk of chick hosts, at a distance from the neural tube,
Fig. 4
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are sewhere we expected no inducing activity to be present. The
grafts were placed over the intermediate and lateral plate
mesoderm, at the level of the first newly formed somite or the
rostral segmental plate (Fig. 4A). The chimeras were allowed
to develop for 9-27 hours and then scored for Pax-3-positive
quail cells. The results are presented graphically in Fig. 4B.
Already at the 4-ss, 25% of grafts yielded a few (<10) Pax-3-
positive cells. As the donor age increased, the percentage of
grafts yielding Pax-3-positive cells also increased, until by the
10- to 11-ss, all grafts yielded Pax-3-positive cells. This
apparently linear progression, however, hides a significant
change in the number of Pax-3-positive cells per graft that
occurs at the 8-ss. Before the 8-ss, 96% of grafts yielded fewer
than ten Pax-3-positive cells (the single exception was from a
7-ss donor); after the 8-ss, 88% of grafts yielded more than
twenty Pax-3-positive cells. Hence commitment of significant
numbers of cells in the explanted region occurs from the 8-ss
onwards. We allowed several embryos that received grafts of
5- to 6-ss midbrain-level ectoderm to develop for 36 hours and
immunostained sections with QCPN and an anti-neurofilament
antibody. A few neurofilament-positive quail cells were seen
in these embryos (data not shown), suggesting that the Pax-3-
positive cells also go on to express neuronal markers.
Any definitive analysis of commitment is difficult to
achieve, because other Pax-3-inducing signals may be present
at the graft site. To eliminate the possibility that Pax-3-
inducing signals are present in underlying lateral plate or
adjacent paraxial mesoderm, we co-cultured 4- to 7-ss
midbrain-level quail ectoderm pieces with isolated 10- to 13-
ss chick lateral plate mesoderm or somitic mesoderm, in
collagen gels without serum for 11-14 hours. When co-cultured
with lateral plate mesoderm, 8% of explants yielded a few (<5)
Pax-3-positive quail cells (n=13). When co-cultured with
somitic mesoderm (segmental plate and somites), 29% of
explants yielded a few (<5) Pax-3-positive quail cells (n=14).
Given that 5- to 7-ss midbrain-level ectoderm cultured alone
yielded Pax-3-positive cells in 24% of cases (Fig. 3A), it seems
unlikely that the underlying mesoderm is involved in inducing
Pax-3 in lateral trunk grafts of unspecified midbrain-level
ectoderm.
152 C. V. H. Baker and othersThe Pax-3-inducing activity is present at all axial
levels
We previously showed that blocking normal interactions
between the neural tube and the presumptive opV placode in
4- to 8-ss chick embryos prevents placodal Pax-3 mRNA
expression, implicating the neural tube in opV placode
induction (Stark et al., 1997). In order to map the spatial extent
of the inducing activity, we grafted midbrain-level ectoderm
(region A) from 3- to 7-ss donor quail embryos next to the
neural tube of host chick embryos at different axial levels (Fig.
5A). At the 3- to 7-ss, midbrain-level ectoderm is essentially
unspecified: combining the specification results described
above for 3- to 4-ss and 5- to 7-ss explants shows that only
19% of 3- to 7-ss explants contained any (1-6) Pax-3-positive
cells (total n=62). Thus this ectoderm can be used to assay the
distribution of Pax-3-inducing activity. Chimeric embryos
were collected after 13-27 hours of incubation and scored for
Pax-3-positive quail cells. In grafts next to the hindbrain (3- to
7-ss hosts), quail tissue was scored independently for Pax-3
expression at each rhombomeric level, since the graft tissue
often overlapped several rhombomeres. In trunk grafts, the
donor ectoderm was usually placed over the first few newly
formed somites or the segmental plate. Since somite formation
is similar along the length of the axis, the ectoderm was thus
grafted to sites that were considered to be at the same relative
developmental stage. The results are depicted graphically in
Fig. 5B.
Pax-3-positive quail cells (5-20 or more) were always found
after grafts of midbrain-level ectoderm to the otic region (A-C
grafts; Fig. 5C-E), nodose placode (A-D grafts) and trunk (A-
M grafts; Fig. 5F-H). These results suggest that the inducing
activity is present not only in the midbrain, where the opV
placode normally forms, but also in the hindbrain and in trunk-
level neural tube. In all three types of grafts, fewer Pax-3-
positive quail cells were present than were seen in isotopic
midbrain-level grafts (data not shown). This suggests either
that less inducing activity is present in the hindbrain and trunk,
or that the grafted quail cells respond to other signals and
become committed to a different fate. For example, when grafts
were positioned precisely at the level of the otic placode, Pax-
3-negative quail cells were often incorporated into the host otic
vesicle (Fig. 5E). The long-term fate of heterotopically grafted
opV placode cells will be addressed in detail in a subsequent
paper.
When 4- to 6-ss midbrain-level ectoderm was grafted next
to r2,3 (A-B grafts), only 78% of grafts contained Pax-3-
positive cells. Again, there were fewer Pax-3-positive quail
cells than in isotopic midbrain-level grafts (data not shown).
Even 8-ss midbrain-level ectoderm, which is already beginning
to express Pax-3 in the embryo, sometimes did not express Pax-
3 when grafted to the r2,3 level (two out of four grafts were
Pax-3-negative). R2,3-level ectoderm is competent to express
Pax-3 when grafted into the midbrain or into the trunk (see
later), but it does not express Pax-3 in normal development.
This may suggest either that the level of inducer is reduced at
the r2,3 level, or that an inhibitor is present in this region.
At midbrain levels, the inducing activity decreases
after the 8-ss
Young (2- to 3-ss) otic-level ectoderm is competent to express
Pax-3 in response to the midbrain-level-inducing activity of 3-to 6-ss hosts, as described above. However, when 2- to 3-ss
otic-level ectoderm was grafted into 9- to 12-ss hosts, only 14%
formed Pax-3-positive cells (n=7; the single positive case was
grafted into a 9-ss host). This may suggest that the level of the
inducing activity in the midbrain decreases after the 8-ss.
The neural tube induces Pax-3 directly in competent
ectoderm
We previously showed that the midbrain/rostral hindbrain is
necessary for Pax-3 mRNA induction in the opV placode, as a
barrier placed between the neural tube and ectoderm in this
region eliminated placodal Pax-3 expression (Stark et al.,
1997). We could not tell from these experiments whether the
neural tube-derived-inducing activity acts directly on the
ectoderm or indirectly via other tissues. We now tested whether
the neural tube is sufficient to induce Pax-3 protein directly in
presumptive opV placode ectoderm, by co-culturing
unspecified midbrain-level quail ectoderm with isolated chick
neural tube in collagen gels without serum for 11-18 hours.
In co-cultures with 4- to 8-ss midbrain, 3- to 7-ss midbrain-
level quail ectoderm formed 10-20 Pax-3-positive cells in 46%
of cases (n=13; Fig. 6A-C). As described above, 3- to 7-ss
ectoderm cultured alone forms a few (1-6) Pax-3-positive cells
in 19% of cases. Thus, many more Pax-3-positive quail cells
were seen after co-culture with midbrain than after culturing
in isolation. We conclude that the midbrain can directly induce
Pax-3 expression in presumptive opV placode ectoderm.
In co-cultures with 10- to 13-ss trunk neural tube, 3- to 7-ss
midbrain-level ectoderm gave rise to ten to twenty or more
Pax-3-positive cells in 55% of cases (n=22; Fig. 6D-F). Again,
many more Pax-3-positive cells were seen per co-culture than
when the ectoderm is cultured alone. The dorsoventral
orientation of the trunk neural tube is evident in section, as the
dorsal neural tube faintly expresses Pax-3 (see Fig. 6D). When
the results are broken down into dorsally versus ventrally
located ectoderm pieces, it is clear that the Pax-3-inducing
activity is localised to the dorsal neural tube. 73% of dorsally
located explants yielded Pax-3-positive cells (n=11), compared
with 18% of ventrally located explants (n=11). Furthermore,
Pax-3-positive cells seen in ventrally located explants were all
in regions of the explant that extended dorsally and were
adjacent to Pax-3-expressing regions of the neural tube; they
were never seen next to the Pax-3-negative ventral neural tube.
These results therefore demonstrate both that trunk neural tube
can directly induce Pax-3 in competent ectoderm and that the
inducing activity is localised to the dorsal neural tube.
A few cells in r3- and young otic-level ectoderm are
also specified to express Pax-3
Since all head ectoderm rostral to the first somite is competent
at the 3-ss to respond to the Pax-3-inducing activity, which is
present throughout the neural tube (see above), we wondered
whether any non-opV head ectoderm is ever specified to express
Pax-3. We explanted r3- and otic-level ectoderm pieces from
quail donors into collagen gels and cultured them without serum
for 18-21 hours. R3-level ectoderm from 6- to 12-ss donors
formed a few (<5) Pax-3-positive cells in 36% of cases (n=28).
Otic-level ectoderm from 2- to 3-ss donors formed a few (<5)
Pax-3-positive cells in 27% of cases (n=11). These results show
(1) that hindbrain-level ectoderm normally receives the
inductive signal, as suggested by our analysis of the spatial
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these regions are specified to express Pax-3. Older otic-level
ectoderm (6- to 13-ss donors), which was previously shown to
lack competence to express Pax-3 (see above), never formed
Pax-3-positive cells in culture (n=14). Therefore, this region of
ectoderm has presumably received other signals by the 6-ss that
forestall any Pax-3 expression. Similarly, since r3-level
ectoderm does not express Pax-3 in vivo (as seen both by whole-
mount in situ hybridisation and after isotopic grafts; Stark et al.,
1997; current results), Pax-3 expression at this level is prevented
in vivo. As expected, trunk ectoderm overlying the lateral plate
mesoderm (7- to 9-ss donors), which was previously shown to
lack competence to express Pax-3 (see above), never gave rise
to Pax-3-positive cells in culture (n=10).
DISCUSSION
Our aim is to understand the cellular and molecular
mechanisms underlying the formation of the trigeminal
placode. We previously showed that the transcription factor
Pax-3 is an early marker for the avian ophthalmic trigeminal
(opV) placode and we identified a diffusible inducing activity
from the midbrain/rostral hindbrain as being necessary for Pax-
3 induction in the opV placode (Stark et al., 1997). Here, we
determined which regions of ectoderm in the embryo are
competent to respond to Pax-3-inducing signals and when they
are competent to do so. We also examined in detail the time
course of specification and commitment of presumptive opV
placode cells to a Pax-3-expressing fate. This enabled us to
determine when and where the Pax-3-inducing activity appears
and to demonstrate that the neural tube induces Pax-3 directly
in competent ectoderm. This allows us to propose a detailed
model for Pax-3 induction in the opV placode.
Spatial and temporal distribution of competent
ectoderm
At the 3-ss, the entire head ectoderm rostral to the first somite
is competent to express Pax-3 in response to the midbrain-
level-inducing activity, as shown by grafting different regions
of ectoderm next to the midbrain. This is supported by our
previous experiments showing normal Pax-3 mRNA
expression after radical surface ectoderm ablation in the opV
placode region (Stark et al., 1997), suggesting that adjacent
ectoderm can respond to the Pax-3-inducing activity. Likewise,
Hamburger (1961) showed that the opV ganglion forms after
ablation of the opV placode.
Competence is lower in more caudal regions, however, and
after the 3-ss, it is lost altogether from the otic region. It is
retained by some tissue that does not normally express Pax-3,
such as r2,3-level ectoderm. Competence is present in
prospective ectoderm early, during gastrulation. It is worth
noting that competence is in all probability also induced or
regulated by signalling molecules (see Streit et al., 1997). Its
loss, for example in the otic region, may be due to commitment
to a different fate.
Trunk ectoderm is not competent to respond to the midbrain-
level Pax-3-inducing activity. However, Vogel and Davies
(1993) showed that trunk ectoderm is competent to form
nodose-type neurons after grafting into the presumptive nodose
placode region, at the level of the first two somites.Importantly, this shows that competence to form one placode
does not necessarily indicate competence to form all placodes.
Specification to express Pax-3
We explanted midbrain-level ectoderm at different times and
tested when it was specified to express Pax-3 by culturing it in
collagen gels without serum. We found that Pax-3 specification
does not occur significantly before Pax-3 expression. In some
embryos, a few cells in the explanted region are specified to
express Pax-3 protein before the 6- to 7-ss stage, which is when
Pax-3 protein expression is first seen in the embryo (Fig. 1).
However, this specification may be concurrent with Pax-3 mRNA
expression, which begins before Pax-3 protein expression (see
above and Stark et al., 1997). Increasing numbers of cells are
specified from the 8-ss onwards, which is probably when Pax-3
protein begins to be expressed in vivo at higher levels.
Commitment to express Pax-3
In order to test commitment, we grafted midbrain-level
ectoderm to the alien environment of the trunk, over the lateral
plate mesoderm and therefore at a distance from the neural
tube. We expected that no inducing activity would be present
in this location. We found that significant numbers of cells in
midbrain-level ectoderm are committed to express Pax-3 after
the 8-ss, which is similar to the result obtained in the
specification experiments. At each stage, however, the
percentage of explants yielding Pax-3-positive cells was
greater when they were grafted into the embryo (commitment
experiments) than when they were cultured alone (specification
experiments). This may not be surprising given that many other
signals are present in the embryonic environment, some of
which may be able to induce or support Pax-3 expression. We
eliminated the underlying mesoderm as a potential source of
additional Pax-3-inducing activity by co-culturing unspecified
midbrain-level ectoderm with isolated lateral plate or somitic
mesoderm. The percentage of explants yielding Pax-3-positive
cells was not significantly increased after co-culture with either
tissue. However, we cannot completely exclude the possibility
that other Pax-3-inducing signals are present in this ectopic
location. These results highlight the difficulty involved in
testing commitment towards a particular fate.
Spatial and temporal distribution of Pax-3-inducing
activity
We were able to use the essentially unspecified nature of 3- to
7-ss midbrain-level ectoderm to analyse the distribution of the
inducing activity in the embryo, by grafting it next to the neural
tube at different axial levels and looking for Pax-3 induction.
The inducing activity is present at all axial levels, although the
fact that midbrain-level ectoderm sometimes did not express
Pax-3 when grafted to the r2,3 level suggests that there may be
less inducer, or perhaps an inhibitor, at this level (see below).
We showed that the neural tube can directly induce Pax-3 in
unspecified ectoderm by co-culturing such ectoderm with
isolated midbrain or trunk neural tube. These data also revealed
that the inducing activity in the trunk is localised to the dorsal
neural tube.
Our previous data suggested that the Pax-3-inducing activity
must be present in the midbrain before the 3-ss, since Pax-3
mRNA can be seen in the ectoderm immediately adjacent to
the midbrain at the 3-ss (Stark et al., 1997). The level of the
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Fig. 5. Analysis of the distribution of inducing
activity. (A) Unspecified midbrain-level
ectoderm from 3- to 7-ss quail donors was
grafted next to the neural tube at different axial
levels. (B) Histogram of the results. Each
column represents the percentage of chimeras
containing Pax-3-positive quail cells; the total
number of grafts performed is marked at the
top of each column. Shown are isotopic
midbrain-level grafts (A-A; 100%), r2-3-level
grafts (A-B; 78%), otic-level grafts (A-C;
100%), and trunk-level grafts adjacent to the
neural tube, over the paraxial mesoderm (A-M;
100%). (C-E) Transverse section at the otic
level of a chick host collected 18 hours after
receiving a graft of 6-ss midbrain-level quail
ectoderm. (C) FITC-labelled Pax-3-positive
cells (green) reside near the neural tube, medial
to the rostral margin of the otic vesicle (ov). hb,
hindbrain. (D) TRITC-labelled QCPN-positive
quail cells (red) are seen in the same region.
(E) Merging the green and red channels shows
that all the Pax-3-positive cells are quail cells
(yellow), and that some Pax-3-negative quail
cells have integrated into the developing otic
vesicle. (F-H) Transverse section through the
trunk region of a chick host collected 19 hours
after receiving a graft of 6-ss midbrain-level
quail ectoderm over the segmental plate.
(F) FITC-labelled Pax-3-positive cells (green)
reside within the surface ectoderm and
dermomyotome (dm). scl, sclerotome; nt,
neural tube. (G) TRITC-labelled QCPN-
positive quail cells (red) reside in the ectoderm
and underlying mesenchyme. (H) Merging the
green and red channels shows that brightly
staining Pax-3-positive cells in the ectoderm
and underlying mesenchyme are quail-derived
(yellow), and that host dermomyotome cells
contain slightly lower levels of Pax-3 protein
(A). dm, dermomyotome; hb, hindbrain; nt, neural tube; ov, otic vesicle; scl, sclerotome.
Fig. 6. The neural tube can
directly induce Pax-3 expression
in presumptive opV placode
ectoderm. 3- to 7-ss midbrain-
level quail ectoderm was co-
cultured with isolated chick
midbrain or trunk neural tube, in
collagen gels without serum for
11-18 hours. (A-C) Section
through a 14.5-hour co-culture of
5- to 6-ss midbrain-level quail
ectoderm (i.e. from a pool of 5-
to 6-ss ectoderm pieces) with
isolated 6-ss chick midbrain.
(A) FITC-labelled Pax-3-positive
cells appear green. (B) TRITC-
labelled QCPN-positive quail
cells appear red. (C) When the
green and red channels are
merged, Pax-3-positive quail cells are seen as yellow (arrowhead). A few Pax-3-positive chick cells are also visible in the midbrain. (D-F) Section
through a 13.5-hour co-culture of 4- to 7-ss midbrain-level quail ectoderm (i.e. from a pool of 4- to 7-ss ectoderm pieces) with isolated chick trunk
neural tube. (D) FITC-labelled Pax-3-positive cells appear green. The dorsal neural tube (d) expresses Pax-3, while the ventral portion (v) does not.
(E) TRITC-labelled QCPN-positive quail cells appear red. (F) When the green and red channels are merged, Pax-3-positive quail cells are seen as
yellow (arrowhead). The dorsal neural tube is also faintly Pax-3-positive, with some scattered brightly staining cells. d, dorsal; v, ventral.
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the stage at which more lateral midbrain-level ectoderm (the
region explanted in our experiments) begins to express
increasing amounts of Pax-3 protein in vivo. This is also the
stage at which neural crest cells migrate beneath the ectoderm.
However, we showed previously that deletion of the neural
crest has no effect on Pax-3 expression in the opV placode
(Stark et al., 1997). In addition, Pax-3 mRNA expression and
at least some Pax-3 specification precede neural crest cell
emigration (Stark et al., 1997; current results). Hence, the
presence of the neural crest is not necessary for Pax-3 induction
in the opV placode.
How is Pax-3 induction restricted?
In the present study, we have shown that a broad area of head
ectoderm is competent to respond to the Pax-3-inducing
activity at the 3-ss, that the inducing activity must be present
in the midbrain before the 3-ss and that the inducing activity
is also broadly distributed along the entire neuraxis. How, then,
is Pax-3 induction localised next to the midbrain and r1?
Firstly, the response is confined to competent ectoderm.
Some regions lack competence from the earliest time tested:
neither trunk ectoderm nor the nodose placode region
(overlying and adjacent to the first two somites) is competent
to express Pax-3. Other regions are competent at early stages,
but subsequently lose competence. For example, otic-level
ectoderm is competent at the 3-ss (and even specified to
express Pax-3 to some extent), but loses competence after this
stage. This loss of competence probably occurs as otic-level
ectoderm becomes committed or more biased towards an otic
fate.
Secondly, a localised inhibitor may prevent the response in
certain regions of competent ectoderm. Ectoderm at the r2,3
level, which marks the caudal boundary of the opV placode, is
competent to express Pax-3 until at least the 9-ss, by which
time midbrain-r1-level ectoderm already expresses Pax-3
protein. A few cells in r3-level ectoderm are even specified to
express Pax-3, but Pax-3 expression is never seen here in vivo.
Either the level of inducer is much reduced at this level or an
inhibitor of Pax-3 expression may be present. Another
alternative, given that neural crest cells exiting at r3 undergo
apoptosis in response to a signal from r4 (Graham et al., 1993,
1994, 1996), is that Pax-3-expressing cells in r3-level ectoderm
also die in response to this signal. The presence of an inhibitor
of some kind is also suggested by the fact that even midbrain-
level ectoderm sometimes does not express Pax-3 when grafted
to the r2,3 level.
Properties of embryonic induction
Our results illustrate three general points about embryonic
induction (Gurdon, 1987; Jacobson and Sater, 1988). Firstly,
the state of the responding tissue is more important than the
state of the inducing tissue in determining the outcome of the
induction: the Pax-3-inducing activity is broadly distributed,
but Pax-3 expression is nevertheless restricted to the midbrain-
r1 level. Secondly, both changes in competence and
suppressive tissue interactions can limit the extent of the
induction: caudal ectoderm regions lack competence
altogether; otic-level ectoderm loses competence, while there
may be an inhibitor at the r2,3-level. Thirdly, the same tissue
can receive several different inductive signals simultaneously,and may be specified in some degree towards a number of
different fates: some cells in r3- and otic-level ectoderm are
specified to express Pax-3. Induction is a cumulative process.
The eventual fate adopted by a tissue therefore depends both
on its history, i.e. signals received in the past that bias it
towards a particular fate, and on signals received at any given
time.
Are placodes derived from a common anlage?
It is possible that the ability of early placodal ectoderm to
respond to many different placode-inducing signals reflects its
derivation from a common anlage. In frog embryos, Knouff
(1935) identified a ‘primitive placodal thickening’ between the
neural crest and epidermis, from which all the placodes
subsequently arise. In the Atlantic cod embryo, Miyake et al.
(1997) found a continuous dorsal ectodermal thickening from
the forebrain to the hindbrain that subsequently separates into
three independent placodes. In mouse embryos, Verwoerd and
van Oostrom (1979) found that the entire head ectoderm is
initially thickened, but subsequently thins to leave the placodes
in relief (they thicken additionally later in development). These
morphological data suggest that placodes arise in
embryogenesis from a common anlage lying between the
neural plate and epidermis. This anlage could be formed by a
mechanism similar to that underlying the initial induction of
the neural crest (reviewed in Baker and Bronner-Fraser, 1997a;
also see Neave et al., 1997). If this is the case, it could account
for some of the similarities between placodal cells and neural
crest cells (reviewed in Baker and Bronner-Fraser, 1997b). As
more is learned about the induction of different placodes, it will
be possible to test this hypothesis.
Conclusion
Pax-3 induction in the presumptive opV placode at the
midbrain level begins before the 3-ss. The whole head
ectoderm rostral to the first somite is competent at the 3-ss to
respond to the midbrain-level Pax-3-inducing activity, but
competence is rapidly lost by the otic region. Pax-3
specification does not occur significantly before Pax-3
expression. The inducing activity is broadly distributed along
the entire neuraxis and the neural tube can directly induce Pax-
3 expression in competent ectoderm. The caudal border of Pax-
3 expression in the opV placode may be defined by an inhibitor
at the r2,3 level. Our detailed analysis of this induction is the
first such for any of the solely neurogenic placodes.
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